{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T12:19:11Z","timestamp":1767183551039,"version":"3.44.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,20]],"date-time":"2024-01-20T00:00:00Z","timestamp":1705708800000},"content-version":"vor","delay-in-days":3306,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32 PD10032525","5K12HD001265-14"],"award-info":[{"award-number":["T32 PD10032525","5K12HD001265-14"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.fertnstert.2014.09.042","type":"journal-article","created":{"date-parts":[[2014,11,6]],"date-time":"2014-11-06T12:26:31Z","timestamp":1415276791000},"page":"264-269","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Use of gonadotropin-releasing hormone agonist trigger during in\u00a0vitro fertilization is associated with similar endocrine profiles and oocyte measures in women with and without polycystic ovary syndrome"],"prefix":"10.1016","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1980-6840","authenticated-orcid":false,"given":"Kathleen E.","family":"O'Neill","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suneeta","family":"Senapati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anuja","family":"Dokras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2014.09.042_bib1","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0015-0282(16)54474-4","article-title":"Induction of preovulatory luteinizing hormone surge and prevention of ovarian hyperstimulation syndrome by gonadotropin-releasing hormone agonist","volume":"56","author":"Itskovitz","year":"1991","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.09.042_bib2","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1210\/jcem-71-4-918","article-title":"Use of gonadotropin-releasing hormone agonist to trigger follicular maturation for in\u00a0vitro fertilization","volume":"71","author":"Gonen","year":"1990","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2014.09.042_bib3","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S1472-6483(10)61826-3","article-title":"Effect of FSH and its different isoforms on maturation of oocytes from pre-ovulatory follicles","volume":"5","author":"Yding Andersen","year":"2002","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2014.09.042_bib4","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1093\/oxfordjournals.humrep.a136151","article-title":"Follicle stimulating hormone alone supports follicle growth and oocyte development in gonadotrophin-releasing hormone antagonist-treated monkeys","volume":"10","author":"Zelinski-Wooten","year":"1995","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2014.09.042_bib5","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/281483a0","article-title":"FSH stimulates hyaluronic acid synthesis by oocyte-cumulus cell complexes from mouse preovulatory follicles","volume":"281","author":"Eppig","year":"1979","journal-title":"Nature"},{"key":"10.1016\/j.fertnstert.2014.09.042_bib6","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1210\/jcem-57-4-792","article-title":"Hormonal dynamics at midcycle: a reevaluation","volume":"57","author":"Hoff","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2014.09.042_bib7","doi-asserted-by":"crossref","first-page":"9163","DOI":"10.1016\/S0021-9258(19)40704-7","article-title":"Role of carbohydrate of human chorionic gonadotropin in the mechanism of hormone action","volume":"250","author":"Moyle","year":"1975","journal-title":"J Biol Chem"},{"key":"10.1016\/j.fertnstert.2014.09.042_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.fertnstert.2003.05.032","article-title":"Luteolysis induced by a gonadotropin-releasing hormone agonist is the key to prevention of ovarian hyperstimulation syndrome","volume":"81","author":"Kol","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.09.042_bib9","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.fertnstert.2007.02.002","volume":"89","author":"Engmann","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.09.042_bib10","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.fertnstert.2009.10.034","article-title":"Gonadotropin-releasing hormone agonist to induce final oocyte maturation prevents the development of ovarian hyperstimulation syndrome in high-risk patients and leads to improved clinical outcomes compared with coasting","volume":"94","author":"DiLuigi","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.09.042_bib11","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.1093\/humrep\/dei190","article-title":"GnRH agonist (buserelin) or HCG for ovulation induction in GnRH antagonist IVF\/ICSI cycles: a prospective randomized study","volume":"20","author":"Engmann","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2014.09.042_bib12","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1093\/oxfordjournals.humrep.a019407","article-title":"Comparison of gonadotrophin-releasing hormone analogues and human chorionic gonadotrophin for the induction of ovulation and prevention of ovarian hyperstimulation syndrome: a case-control study","volume":"11","author":"Lewit","year":"1996","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2014.09.042_bib13","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.rbmo.2011.11.001","article-title":"The luteal phase after GnRH-agonist triggering of ovulation: present and future perspectives","volume":"24","author":"Humaidan","year":"2012","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2014.09.042_bib14","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1210\/jcem.87.2.8197","article-title":"Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after cotreatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in\u00a0vitro fertilization","volume":"87","author":"Fauser","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2014.09.042_bib15","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1093\/humrep\/dei150","article-title":"A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists","volume":"20","author":"Kolibianakis","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2014.09.042_bib16","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1093\/humrep\/deh765","article-title":"GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF\/ICSI cycles: a prospective randomized study","volume":"20","author":"Humaidan","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2014.09.042_bib17","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1016\/j.fertnstert.2011.01.163","volume":"95","author":"Griesinger","year":"2011","journal-title":"Fertil Steril"},{"doi-asserted-by":"crossref","unstructured":"Youssef MA, Van der Veen F, Al-Inany HG, Griesinger G, Mochtar MH, Aboulfoutouh I, et al. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles. Cochrane Database Syst Rev 2011;CD008046.","key":"10.1016\/j.fertnstert.2014.09.042_bib18","DOI":"10.1002\/14651858.CD008046.pub3"},{"key":"10.1016\/j.fertnstert.2014.09.042_bib19","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/S0015-0282(03)00177-8","article-title":"Lower levels of inhibin A and pro-alphaC during the luteal phase after triggering oocyte maturation with a gonadotropin-releasing hormone agonist versus human chorionic gonadotropin","volume":"79","author":"Nevo","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.09.042_bib20","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.fertnstert.2007.04.006","article-title":"The effect of luteal phase vaginal estradiol supplementation on the success of in\u00a0vitro fertilization treatment: a prospective randomized study","volume":"89","author":"Engmann","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.09.042_bib21","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1093\/humrep\/det304","article-title":"Consistent high clinical pregnancy rates and low ovarian hyperstimulation syndrome rates in high-risk patients after GnRH agonist triggering and modified luteal support: a retrospective multicentre study","volume":"28","author":"Iliodromiti","year":"2013","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2014.09.042_bib22","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1016\/j.fertnstert.2011.03.109","article-title":"Comparison of \u201ctriggers\u201d using leuprolide acetate alone or in combination with low-dose human chorionic gonadotropin","volume":"95","author":"Shapiro","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.09.042_bib23","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ejogrb.2011.03.002","article-title":"Failure of triggering oocyte maturation with a GnRH agonist in polycystic ovary syndrome: two case reports","volume":"157","author":"Honnma","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.fertnstert.2014.09.042_bib24","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s10815-011-9704-8","article-title":"Empty follicle syndrome after GnRHa triggering versus hCG triggering in COS","volume":"29","author":"Castillo","year":"2012","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2014.09.042_bib25","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.steroids.2011.12.007","article-title":"Neuroendocrine dysfunction in polycystic ovary syndrome","volume":"77","author":"Burt Solorzano","year":"2012","journal-title":"Steroids"},{"key":"10.1016\/j.fertnstert.2014.09.042_bib26","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/humrep\/des361","article-title":"Predicting successful induction of oocyte maturation after gonadotropin-releasing hormone agonist (GnRHa) trigger","volume":"28","author":"Kummer","year":"2013","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2014.09.042_bib27","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.fertnstert.2010.09.009","article-title":"Efficacy of induced luteinizing hormone surge after \u201ctrigger\u201d with gonadotropin-releasing hormone agonist","volume":"95","author":"Shapiro","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.09.042_bib28","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1093\/humrep\/des049","article-title":"Circulating luteinizing hormone level after triggering oocyte maturation with GnRH agonist may predict oocyte yield in flexible GnRH antagonist protocol","volume":"27","author":"Chen","year":"2012","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2014.09.042_bib29","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/00006254-198906000-00004","article-title":"Ovarian hyperstimulation syndrome: an update review","volume":"44","author":"Golan","year":"1989","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.fertnstert.2014.09.042_bib30","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/humrep\/deq306","article-title":"Female obesity adversely affects assisted reproductive technology (ART) pregnancy and live birth rates","volume":"26","author":"Luke","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2014.09.042_bib31","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.09.042_bib32","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1093\/humupd\/dmr008","article-title":"GnRH agonist for triggering of final oocyte maturation: time for a change of practice?","volume":"17","author":"Humaidan","year":"2011","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2014.09.042_bib33","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/humupd\/dmq032","article-title":"Extra- and intra-ovarian factors in polycystic ovary syndrome: impact on oocyte maturation and embryo developmental competence","volume":"17","author":"Qiao","year":"2011","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2014.09.042_bib34","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1093\/humrep\/des216","article-title":"A decrease in serum estradiol levels after human chorionic gonadotrophin administration predicts significantly lower clinical pregnancy and live birth rates in in\u00a0vitro fertilization cycles","volume":"27","author":"Kondapalli","year":"2012","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2014.09.042_bib35","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/humupd\/dmn015","article-title":"Follicle dynamics and anovulation in polycystic ovary syndrome","volume":"14","author":"Franks","year":"2008","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2014.09.042_bib36","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1093\/humupd\/dml017","article-title":"The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome","volume":"12","author":"Blank","year":"2006","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2014.09.042_bib37","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.fertnstert.2013.02.055","article-title":"Is the fertile window extended in women with polycystic ovary syndrome? Utilizing the Society for Assisted Reproductive Technology registry to assess the impact of reproductive aging on live-birth rate","volume":"100","author":"Kalra","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.09.042_bib38","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/oxfordjournals.humrep.a138029","article-title":"A controlled study comparing patients with and without polycystic ovaries undergoing in-vitro fertilization","volume":"8","author":"MacDougall","year":"1993","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2014.09.042_bib39","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ejogrb.2009.11.017","article-title":"IVF outcome in women with PCOS, PCO and normal ovarian morphology","volume":"149","author":"Swanton","year":"2010","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.fertnstert.2014.09.042_bib40","doi-asserted-by":"crossref","first-page":"e91796","DOI":"10.1371\/journal.pone.0091796","article-title":"Is a GnRH antagonist protocol better in PCOS patients? A meta-analysis of RCTs","volume":"9","author":"Lin","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.fertnstert.2014.09.042_bib41","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0015-0282(16)53348-2","article-title":"Severe ovarian hyperstimulation syndrome using agonists of gonadotropin-releasing hormone for in\u00a0vitro fertilization: a European series and a proposal for prevention","volume":"53","author":"Forman","year":"1990","journal-title":"Fertil Steril"},{"doi-asserted-by":"crossref","unstructured":"D'Angelo A, Amso N. Embryo freezing for preventing ovarian hyperstimulation syndrome. Cochrane Database Syst Rev 2007;CD002806.","key":"10.1016\/j.fertnstert.2014.09.042_bib42","DOI":"10.1002\/14651858.CD002806.pub2"},{"key":"10.1016\/j.fertnstert.2014.09.042_bib43","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/humrep\/dep436","article-title":"Flexible GnRH antagonist protocol versus GnRH agonist long protocol in patients with polycystic ovary syndrome treated for IVF: a prospective randomised controlled trial (RCT)","volume":"25","author":"Lainas","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2014.09.042_bib44","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1210\/jc.2007-0409","article-title":"Dopamine agonist cabergoline reduces hemoconcentration and ascites in hyperstimulated women undergoing assisted reproduction","volume":"92","author":"Alvarez","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2014.09.042_bib45","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S1472-6483(10)60401-4","article-title":"Cabergoline reduces the early onset of ovarian hyperstimulation syndrome: a prospective randomized study","volume":"17","author":"Carizza","year":"2008","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2014.09.042_bib46","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1016\/j.fertnstert.2009.01.085","article-title":"Low-dose aspirin therapy to prevent ovarian hyperstimulation syndrome","volume":"93","author":"Varnagy","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.09.042_bib47","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1093\/humrep\/17.5.1212","article-title":"\u201cEarly coasting\u201d in patients with polycystic ovarian syndrome is consistent with good clinical outcome","volume":"17","author":"Egbase","year":"2002","journal-title":"Hum Reprod"},{"doi-asserted-by":"crossref","unstructured":"Tso LO, Costello MF, Albuquerque LE, Andriolo RB, Freitas V. Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome. Cochrane Database Syst Rev 2009;CD006105.","key":"10.1016\/j.fertnstert.2014.09.042_bib48","DOI":"10.1002\/14651858.CD006105.pub2"},{"key":"10.1016\/j.fertnstert.2014.09.042_bib49","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.fertnstert.2008.12.019","article-title":"Triggering ovulation with gonadotropin-releasing hormone agonist in in\u00a0vitro fertilization patients with polycystic ovaries does not cause ovarian hyperstimulation syndrome despite very high estradiol levels","volume":"93","author":"Manzanares","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.09.042_bib50","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.rbmo.2012.11.002","article-title":"GnRH agonist triggering: recent developments","volume":"26","author":"Kol","year":"2013","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2014.09.042_bib51","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S1472-6483(10)60006-5","article-title":"Luteal phase rescue in high-risk OHSS patients by GnRHa triggering in combination with low-dose HCG: a pilot study","volume":"18","author":"Humaidan","year":"2009","journal-title":"Reprod Biomed Online"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028214022249?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028214022249?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T08:15:41Z","timestamp":1758010541000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028214022249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0015028214022249"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2014.09.042","relation":{},"ISSN":["0015-0282"],"issn-type":[{"type":"print","value":"0015-0282"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of gonadotropin-releasing hormone agonist trigger during in\u00a0vitro fertilization is associated with similar endocrine profiles and oocyte measures in women with and without polycystic ovary syndrome","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2014.09.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}